| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
2.57 0 (0%) |
04-18 13:05 |
|
Open: |
2.54 |
Pre close: |
2.57 |
Target:
|
3.34 
|
|
High: |
2.61 |
Low: |
2.51 |
Resistance:
|
2.86
3.24
|
|
Volume: |
90,209 |
Market Cap: |
74M |
Support:
|
2.24
1.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.65
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
2.62 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
2.60 |
Stochastic Oscillator |
%K(14,3):
|
22.75 |
|
MA(250): |
3.25 |
%D(3): |
30.07 |
|
Average Volume(K) |
3-Month: |
37437
|
52-Week |
High:
|
5.46 |
|
10-Days: |
39941 |
Low: |
2.03 |
|
RSI |
RSI(14):
|
47.88 |
Change(%): |
-25.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.600 |
Return on Equity (ttm) |
-181.2 |
Shares Out. (M) |
28.61 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-51.3 |
Shares Float (M) |
27.89 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
-2.2 |
% Held by Institutions |
88.00 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.570 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.71 |
|
Profit Margin |
-64.90 |
Operating Cash Flow
(M) |
-13.17 |
P/S |
93532688.00 |
|
Operating Margin |
-75.15 |
Levered Free Cash Flow
(M) |
-7.43 |
P/CF |
-5.54 |
|
|
|
|
|
|
